Development and characterisation of acquired radioresistant breast cancer cell lines. https://t.co/ruSsddFUz0
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
RT @Angie_Fawkes: Full genome expression read-counts were generated using @lexogen QuantSeq 3′ FWD sequencing technology on an @illumina Ne…
RT @carlosburgh: Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And…
Full genome expression read-counts were generated using @lexogen QuantSeq 3′ FWD sequencing technology on an @illumina NextSeq High OutPut Flowcell @EdinburghCRF by @seqninja #SequencingTeam
Our paper on breast cancer models of radioresistance is just out on @BioMedCentral & @OncoBioMed’s Radiation Oncology. And it’s #openacess! Check it out here: https://t.co/SaNmCfJrao https://t.co/bpVwQ5hMJ5